CAFs promote stemness and chemotherapy (oxaliplatin) resistance in CRC cells through the transfer of exosomal lncRNA H19; lncRNA H19 acts as an endogenous sponge for miR-141, de-repressing the B-catenin pathway; in vivo, CAF-derived exosomes promoted tumor growth. This evidence concerns the gene H19 and colorectal carcinoma.